Literature DB >> 174719

Cleavage of Type II and III collagens with mammalian collagenase: site of cleavage and primary structure at the NH2-terminal portion of the smaller fragment released from both collagens.

E J Miller, E D Harris, E Chung, J E Finch, P A McCroskery, W T Butler.   

Abstract

Collagenase cleavage of human Type II and III collagens has been studied using a highly purified preparation of rabbit tumor collagenase. Progress of the reactions in solution was followed by viscometry and the results indicated that under the conditions employed Type III collagen molecules were cleaved at approximately five times the rate of Type II molecules. Cleavage products of the reactions were isolated in denatured form by agarose molecular sieve chromatography. The molecular weights and amino acid compositions of the products demonstrated that Type II and III molecules had been cleaved at the characteristic three-quarter, one-quarter locus, giving rise to a large fragment derived from the NH2-terminal portion of the molecule and a smaller fragment representing the COOH-terminal region. The amino acid sequence at the NH2-terminal portion of the smaller fragment derived from Type II collagen was determined to be Ile-Ala-Gly-Gln-Arg, and the corresponding region from Type III collagen was found to have the sequence Leu-Ala Gly-Leu-Arg. These sequences for alpha1(II) and alpha1(III) chains adjacent to the site of collagenase cleavage along with previous data for alpha1(I) and alpha2 chains indicate that the minimum specific sequence required for collagenase cleavage is Gly-Ile-Ala or Gly-Leu-Ala. Inspection of the available sequence data for collagen alpha chains indicates that the latter sequences are found in at least three additional locations at which collagenase cleavage does not occur. Each of the sequences which are apparently not substrates for collagenase, however, are followed by a Gly-X-Hyp sequence. We suggest, then, that a minimum of five residues in collagen alpha chains COOH-terminal to the cleavage site comprise the substrate recognition site.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 174719     DOI: 10.1021/bi00649a009

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  34 in total

1.  Biochemical characteristics and biological significance of the genetically-distinct collagens.

Authors:  E J Miller
Journal:  Mol Cell Biochem       Date:  1976-12-10       Impact factor: 3.396

2.  Granulocyte collagenase: selective digestion of type I relative to type III collagen.

Authors:  A L Horwitz; A J Hance; R G Crystal
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

3.  Purification, characterization and inhibition of human skin collagenase.

Authors:  D E Woolley; R W Glanville; D R Roberts; J M Evanson
Journal:  Biochem J       Date:  1978-02-01       Impact factor: 3.857

4.  Pathology of collagen degradation. A review.

Authors:  R Pérez-Tamayo
Journal:  Am J Pathol       Date:  1978-08       Impact factor: 4.307

5.  Computational sequence analysis of matrix metalloproteinases.

Authors:  Q A Sang; D A Douglas
Journal:  J Protein Chem       Date:  1996-02

6.  Procollagenase activator produced by rabbit uterine cervical fibroblasts.

Authors:  M Ishibashi; A Ito; K Sakyo; Y Mori
Journal:  Biochem J       Date:  1987-01-15       Impact factor: 3.857

7.  Local conformation and dynamics of isoleucine in the collagenase cleavage site provide a recognition signal for matrix metalloproteinases.

Authors:  Jianxi Xiao; Rayna M Addabbo; Janelle L Lauer; Gregg B Fields; Jean Baum
Journal:  J Biol Chem       Date:  2010-08-02       Impact factor: 5.157

8.  Interleukin 13 blocks the release of collagen from bovine nasal cartilage treated with proinflammatory cytokines.

Authors:  C S Cleaver; A D Rowan; T E Cawston
Journal:  Ann Rheum Dis       Date:  2001-02       Impact factor: 19.103

9.  Specific cleavage of human type III and IV collagens by Pseudomonas aeruginosa elastase.

Authors:  L W Heck; K Morihara; W B McRae; E J Miller
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

10.  The tetracycline analogs minocycline and doxycycline inhibit angiogenesis in vitro by a non-metalloproteinase-dependent mechanism.

Authors:  S Gilbertson-Beadling; E A Powers; M Stamp-Cole; P S Scott; T L Wallace; J Copeland; G Petzold; M Mitchell; S Ledbetter; R Poorman
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.